A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
- Donald C. Goff
- , J. Steven Lamberti
- , Andrew C. Leon
- , Michael F. Green
- , Alexander L. Miller
- , Jayendra Patel
- , Theo Manschreck
- , Oliver Freudenreich
- , Steven A. Johnson
- Massachusetts General Hospital
- Freedom Trail Clinic
- University of Rochester
- Cornell University
- University of California at Los Angeles
- University of Texas Health Science Center at San Antonio
- University of Massachusetts Medical School
- Harvard University
- Cortex Pharmaceuticals Inc.
Research output: Contribution to journal › Article › peer-review
178
Scopus
citations